Paper8348751
Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.
Choi-Miura NH and 7 others. Clin Exp Immunol, 1993. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis. Papers, record 8348751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8348751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arteriosclerosis | Major topic |
| Complement System Proteins | Major topic |
| Glycoproteins | Major topic |
| Lipoproteins, HDL | Major topic |
| Molecular Chaperones | Major topic |
| Tangier Disease | Major topic |
| Adult | |
| Clusterin | |
| Complement Membrane Attack Complex | |
| Female | |
| Humans | |
| Lipids |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7130397 | Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier). | J Clin Invest | 1982 | https://conductscience.org/library/papers/7130397 | PubMed |
| 2 | 6790903 | Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease). | Metabolism | 1981 | https://conductscience.org/library/papers/6790903 | PubMed |
| 3 | 6871313 | Ram rete testis fluid contains a protein (clusterin) which influences cell-cell interactions in vitro. | Biol Reprod | 1983 | https://conductscience.org/library/papers/6871313 | PubMed |
| 4 | 6554279 | The activation of human complement component C5 by a fluid phase C5 convertase. | J Biol Chem | 1983 | https://conductscience.org/library/papers/6554279 | PubMed |
| 5 | 6412234 | Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6412234 | PubMed |
| 6 | 6311077 | Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. | Annu Rev Biochem | 1983 | https://conductscience.org/library/papers/6311077 | PubMed |
| 7 | 6651915 | A Japanese family with high density lipoprotein deficiency. | Atherosclerosis | 1983 | https://conductscience.org/library/papers/6651915 | PubMed |
| 8 | 6725246 | Tangier disease. In vitro conversion of proapo-A-ITangier to mature APO-A-ITangier. | J Biol Chem | 1984 | https://conductscience.org/library/papers/6725246 | PubMed |
| 9 | 6432845 | Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6432845 | PubMed |
| 10 | 3910058 | Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. | Atherosclerosis | 1985 | https://conductscience.org/library/papers/3910058 | PubMed |
| 11 | 3511384 | The pathogenesis of atherosclerosis--an update. | N Engl J Med | 1986 | https://conductscience.org/library/papers/3511384 | PubMed |
| 12 | 3056433 | The complement system in atherosclerosis. | Atherosclerosis | 1988 | https://conductscience.org/library/papers/3056433 | PubMed |
| 13 | 2469247 | Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries. | Virchows Arch A Pathol Anat Histopathol | 1989 | https://conductscience.org/library/papers/2469247 | PubMed |
| 14 | 2474572 | Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2474572 | PubMed |
| 15 | 2549301 | Endocytic pathway of high density lipoprotein via trans-Golgi system in rat resident peritoneal macrophages. | Lab Invest | 1989 | https://conductscience.org/library/papers/2549301 | PubMed |
| 16 | 2780565 | Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2780565 | PubMed |
| 17 | 2477686 | Induction of the TRPM-2 gene in cells undergoing programmed death. | Mol Cell Biol | 1989 | https://conductscience.org/library/papers/2477686 | PubMed |
| 18 | 2601725 | A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes. | Mol Immunol | 1989 | https://conductscience.org/library/papers/2601725 | PubMed |
| 19 | 2299741 | Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury. | J Urol | 1990 | https://conductscience.org/library/papers/2299741 | PubMed |
| 20 | 2391426 | Sandwich ELISA assay for quantitative measurement of SP-40,40 in seminal plasma and serum. | J Immunol Methods | 1990 | https://conductscience.org/library/papers/2391426 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28242049 | High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis. | Atherosclerosis | 2017 | https://conductscience.org/library/papers/28242049 | PubMed |
| 15014888 | [A 52-year old female patient with recurrent shock of unclear origin, hemoconcentration and hypoalbuminemia]. | Internist (Berl) | 2004 | https://conductscience.org/library/papers/15014888 | PubMed |
| 8687416 | Apolipoprotein J and Alzheimer's amyloid beta solubility. | Biochem J | 1996 | https://conductscience.org/library/papers/8687416 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOA1 | 335 | PubTator's text mining | https://conductscience.org/library/genes/335 | NCBI Gene |
| APOA2 | 336 | PubTator's text mining | https://conductscience.org/library/genes/336 | NCBI Gene |
| CLU | 1191 | PubTator's text mining | https://conductscience.org/library/genes/1191 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8348751
GET https://conductscience.org/api/papers/v1/8348751/references?page=2